174 related articles for article (PubMed ID: 29649512)
1. 14-3-3 protein directly interacts with the kinase domain of calcium/calmodulin-dependent protein kinase kinase (CaMKK2).
Psenakova K; Petrvalska O; Kylarova S; Lentini Santo D; Kalabova D; Herman P; Obsilova V; Obsil T
Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1612-1625. PubMed ID: 29649512
[TBL] [Abstract][Full Text] [Related]
2. CaMKK2 kinase domain interacts with the autoinhibitory region through the N-terminal lobe including the RP insert.
Kylarova S; Psenakova K; Herman P; Obsilova V; Obsil T
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2304-2313. PubMed ID: 30053538
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3 protein inhibits CaMKK1 by blocking the kinase active site with its last two C-terminal helices.
Petrvalska O; Honzejkova K; Koupilova N; Herman P; Obsilova V; Obsil T
Protein Sci; 2023 Nov; 32(11):e4805. PubMed ID: 37817008
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of Protein-Protein Interactions between CaMKK2 and 14-3-3 by Fusicoccins.
Lentini Santo D; Petrvalska O; Obsilova V; Ottmann C; Obsil T
ACS Chem Biol; 2020 Nov; 15(11):3060-3071. PubMed ID: 33146997
[TBL] [Abstract][Full Text] [Related]
5. Akt activation by Ca
Gocher AM; Azabdaftari G; Euscher LM; Dai S; Karacosta LG; Franke TF; Edelman AM
J Biol Chem; 2017 Aug; 292(34):14188-14204. PubMed ID: 28634229
[TBL] [Abstract][Full Text] [Related]
6. CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins.
Langendorf CG; O'Brien MT; Ngoei KRW; McAloon LM; Dhagat U; Hoque A; Ling NXY; Dite TA; Galic S; Loh K; Parker MW; Oakhill JS; Kemp BE; Scott JW
J Biol Chem; 2020 Nov; 295(48):16239-16250. PubMed ID: 32913128
[TBL] [Abstract][Full Text] [Related]
7. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
8. Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2.
Gerner L; Munack S; Temmerman K; Lawrence-Dörner AM; Besir H; Wilmanns M; Jensen JK; Thiede B; Mills IG; Morth JP
Biochem Biophys Res Commun; 2016 Jul; 476(2):102-7. PubMed ID: 27178209
[TBL] [Abstract][Full Text] [Related]
9. The Phosphatase-Resistant Isoform of CaMKI, Ca²⁺/Calmodulin-Dependent Protein Kinase Iδ (CaMKIδ), Remains in Its "Primed" Form without Ca²⁺ Stimulation.
Senga Y; Ishida A; Shigeri Y; Kameshita I; Sueyoshi N
Biochemistry; 2015 Jun; 54(23):3617-30. PubMed ID: 25994484
[TBL] [Abstract][Full Text] [Related]
10. CaMKK2 is not involved in contraction-stimulated AMPK activation and glucose uptake in skeletal muscle.
Negoita F; Addinsall AB; Hellberg K; Bringas CF; Hafen PS; Sermersheim TJ; Agerholm M; Lewis CTA; Ahwazi D; Ling NXY; Larsen JK; Deshmukh AS; Hossain MA; Oakhill JS; Ochala J; Brault JJ; Sankar U; Drewry DH; Scott JW; Witczak CA; Sakamoto K
Mol Metab; 2023 Sep; 75():101761. PubMed ID: 37380024
[TBL] [Abstract][Full Text] [Related]
11. Autoactivation of C-terminally truncated Ca
Akizuki K; Kinumi T; Ono A; Senga Y; Osawa J; Shigeri Y; Ishida A; Kameshita I; Sueyoshi N
Arch Biochem Biophys; 2019 Jun; 668():29-38. PubMed ID: 31071303
[TBL] [Abstract][Full Text] [Related]
12. Protein ligand interaction analysis against new CaMKK2 inhibitors by use of X-ray crystallography and the fragment molecular orbital (FMO) method.
Takaya D; Niwa H; Mikuni J; Nakamura K; Handa N; Tanaka A; Yokoyama S; Honma T
J Mol Graph Model; 2020 Sep; 99():107599. PubMed ID: 32348940
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcium/calmodulin-dependent protein kinase kinase by protein 14-3-3.
Davare MA; Saneyoshi T; Guire ES; Nygaard SC; Soderling TR
J Biol Chem; 2004 Dec; 279(50):52191-9. PubMed ID: 15469938
[TBL] [Abstract][Full Text] [Related]
14. Binding and structural analyses of potent inhibitors of the human Ca
Profeta GS; Dos Reis CV; Santiago ADS; Godoi PHC; Fala AM; Wells CI; Sartori R; Salmazo APT; Ramos PZ; Massirer KB; Elkins JM; Drewry DH; Gileadi O; Couñago RM
Sci Rep; 2019 Nov; 9(1):16452. PubMed ID: 31712618
[TBL] [Abstract][Full Text] [Related]
15. Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology.
Racioppi L; Means AR
J Biol Chem; 2012 Sep; 287(38):31658-65. PubMed ID: 22778263
[TBL] [Abstract][Full Text] [Related]
16. Oligomerization of Ca
Fukumoto Y; Harada Y; Ohtsuka S; Kanayama N; Magari M; Hatano N; Sakagami H; Tokumitsu H
Biochem Biophys Res Commun; 2022 Jan; 587():160-165. PubMed ID: 34875535
[TBL] [Abstract][Full Text] [Related]
17. Generation of autonomous activity of Ca(2+)/calmodulin-dependent protein kinase kinase β by autophosphorylation.
Tokumitsu H; Hatano N; Fujimoto T; Yurimoto S; Kobayashi R
Biochemistry; 2011 Sep; 50(38):8193-201. PubMed ID: 21859090
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase A negatively regulates VEGF-induced AMPK activation by phosphorylating CaMKK2 at serine 495.
Spengler K; Zibrova D; Woods A; Langendorf CG; Scott JW; Carling D; Heller R
Biochem J; 2020 Sep; 477(17):3453-3469. PubMed ID: 32869834
[TBL] [Abstract][Full Text] [Related]
19. Impact of Genetic Variation on Human CaMKK2 Regulation by Ca
O'Brien MT; Oakhill JS; Ling NX; Langendorf CG; Hoque A; Dite TA; Means AR; Kemp BE; Scott JW
Sci Rep; 2017 Feb; 7():43264. PubMed ID: 28230171
[TBL] [Abstract][Full Text] [Related]
20. The active-site cysteine residue of Ca
Takata T; Tsukuda A; Tsuchiya Y; Akaike T; Watanabe Y
Nitric Oxide; 2019 May; 86():68-75. PubMed ID: 30844494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
